↓ Skip to main content

Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype

Overview of attention for article published in Clinical Cancer Research, July 2005
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
1 news outlet
patent
16 patents

Citations

dimensions_citation
546 Dimensions

Readers on

mendeley
174 Mendeley
citeulike
3 CiteULike
connotea
2 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype
Published in
Clinical Cancer Research, July 2005
DOI 10.1158/1078-0432.ccr-04-2424
Pubmed ID
Authors

Sunil R. Lakhani, Jorge S. Reis-Filho, Laura Fulford, Frederique Penault-Llorca, Marc van der Vijver, Suzanne Parry, Timothy Bishop, Javier Benitez, Carmen Rivas, Yves-Jean Bignon, Jenny Chang-Claude, Ute Hamann, Cees J. Cornelisse, Peter Devilee, Matthias W. Beckmann, Carolin Nestle-Krämling, Peter A. Daly, Neva Haites, Jenny Varley, Fiona Lalloo, Gareth Evans, Christine Maugard, Hanne Meijers-Heijboer, Jan G.M. Klijn, Edith Olah, Barry A. Gusterson, Silvana Pilotti, Paolo Radice, Siegfried Scherneck, Hagay Sobol, Jocelyne Jacquemier, Teresa Wagner, Julian Peto, Michael R. Stratton, Lesley McGuffog, Douglas F. Easton, the Breast Cancer Linkage Consortium

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 174 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 1%
Ireland 1 <1%
Canada 1 <1%
Argentina 1 <1%
Belgium 1 <1%
Russia 1 <1%
Spain 1 <1%
Serbia 1 <1%
Unknown 165 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 36 21%
Researcher 28 16%
Student > Master 23 13%
Student > Bachelor 20 11%
Student > Doctoral Student 14 8%
Other 32 18%
Unknown 21 12%
Readers by discipline Count As %
Medicine and Dentistry 61 35%
Agricultural and Biological Sciences 45 26%
Biochemistry, Genetics and Molecular Biology 35 20%
Engineering 2 1%
Mathematics 1 <1%
Other 5 3%
Unknown 25 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2022.
All research outputs
#1,969,788
of 23,515,383 outputs
Outputs from Clinical Cancer Research
#1,569
of 12,758 outputs
Outputs of similar age
#2,965
of 57,845 outputs
Outputs of similar age from Clinical Cancer Research
#2
of 134 outputs
Altmetric has tracked 23,515,383 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,758 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.2. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 57,845 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 134 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.